MONJUVI

MorphoSys AG

Application Filed: 2019-10-22
Trademark Application Details
Trademark Logo MONJUVI

The mark consists of the wording "MONJUVI" located to the left of three arrow points.

Mark For: MONJUVI™ trademark registration is intended to cover the categories of (Based on 44(d) Priority Application) (Based on Intent to Use) Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies. [all]

>Color is not claimed as a feature of the mark. The mark consists of the wording "MONJUVI" located to the left of three arrow points.

Status

2020-01-22 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88664626
Mark Literal ElementsMONJUVI
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeTRADEMARK. SERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED 2019-12-18
Basis1(b) 44(d)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledYes
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMichael J. Leonard
Attorney Docket Number114353.00088

Timeline

2019-10-22Application Filed
2019-10-25Location: NEW APPLICATION PROCESSING
2019-10-25Status: Live/Pending
2019-10-25Transaction Date
2019-12-16Published for Opposition
2019-12-16Trademark Registered
2019-12-18Location: TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
2019-12-18Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi

Trademark Parties (Applicants & Owners)

Party: MorphoSys AG
AddressSemmelweisstrasse 7 Planegg GERMANY D-82152
Legal Entity TypeAktiengesellschaft
Legal Entity StateGERMANY

Documents

DrawingIMAGE/JPEG2019-10-22
TEAS RF New ApplicationMULTI2019-10-22
Design Search Code Corr ProjectAPPLICATION/XML2019-10-30
Preliminary AmendmentMULTI2019-11-17
Amendment and Mail Process CompleteMULTI2019-11-23
XSearch Search SummaryXML2019-12-15
Notation to FileXML2019-12-18
Offc Action OutgoingXML2019-12-18

Design Search Codes

24.15.10Arrows, more than one; More than one arrow
241504Arrowheads
241510Arrows, more than one; More than one arrow

Attorney of Record

MICHAEL J. LEONARD
FOX ROTHSCHILD LLP
997 LENOX DRIVE, BLDG. 3
LAWRENCEVILLE, NJ 08648-2311

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: (Based on 44(d) Priority Application) (Based on Intent to Use) Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
IC 042. US 100 101. G & S: (Based on 44(d) Priority Application) (Based on Intent to Use) Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
DM0000The mark consists of the wording MONJUVI located to the left of three arrow points.
CC0000Color is not claimed as a feature of the mark.

Trademark Filing History

DescriptionDateProceeding Number
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-12-186325
NON-FINAL ACTION WRITTEN2019-12-1873363
NON-FINAL ACTION E-MAILED2019-12-186325
ASSIGNED TO EXAMINER2019-12-1573363
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED2019-11-2270138
ASSIGNED TO LIE2019-11-2170138
TEAS VOLUNTARY AMENDMENT RECEIVED2019-11-17
NOTICE OF DESIGN SEARCH CODE E-MAILED2019-10-30
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-10-29
NEW APPLICATION ENTERED IN TRAM2019-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed